We are live on ! Find out more
VIVS

VivoSim Labs

39 hedge funds and large institutions have $4.07M invested in VivoSim Labs in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more capital invested

Capital invested by funds: $3.43M → $4.07M (+$642K)

0% more ownership

Funds ownership: 1.92%1.92% (+0%)

7% less funds holding

Funds holding: 4239 (-3)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

50% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 10

Holders
39
Holders Change
-3
Holders Change %
-7.14%
% of All Funds
0.67%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
5
Reduced
10
Closed
6
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$5K

VIVS Hedge Fund Activity: Q3 2022 in Review

39 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q3 2022, worth a combined $4.07M — up 19% from $3.43M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of VIVS and 4 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 5 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $64.6K. The largest seller was Renaissance Technologies, cutting an estimated $102K.

  • 39 institutional investors held VivoSim Labs (VIVS) as of Q3 2022, down from 42 in Q2 2022.
  • Funds reported $4.07M of VivoSim Labs stock for Q3 2022, up 19% quarter-over-quarter.
  • 4 funds opened new VivoSim Labs positions in Q3 2022 and 6 closed out, a net change of -2 holders.
  • The largest VivoSim Labs buyer in Q3 2022 was Millennium Management, an estimated $64.6K added.
  • The largest VivoSim Labs seller in Q3 2022 was Renaissance Technologies, an estimated $102K sold.

Based on aggregated 13F filings for Q3 2022.